INM - InMed Pharmaceuticals Inc.
3.16
0.030 0.949%
Share volume: 1,559
Last Updated: Wed 05 Feb 2025 12:00:04 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.42%
PREVIOUS CLOSE
CHG
CHG%
$3.13
0.03
0.96%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 2024-05-13 | 2024-11-14 | 2024-11-14 | |
| Assets | ||||
| Total Assets | 13.359 M | 11.823 M | 10.465 M | |
| Current Assets | 10.064 M | 8.690 M | 7.280 M | |
| Inventories | 1.194 M | 1.244 M | 1.220 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 43.085 K | 43.064 K | 43.203 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.601 M | 6.572 M | 5.583 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.371 M | 1.250 M | 1.343 M | |
| Other Assets | 1.924 M | 1.883 M | 1.842 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 13.359 M | 11.823 M | 10.465 M | |
| Total liabilities | 2.254 M | 2.617 M | 2.070 M | |
| Total current liabilities | 1.529 M | 1.972 M | 1.436 M | |
| Accounts Payable | 1.183 M | 1.654 M | 1.012 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 11.105 M | 9.206 M | 8.395 M | |
| Common stock | 118.114 M | 118.153 M | 119.021 M | |
| Retained earnings | -107.138 M | -109.076 M | -110.754 M |